Canada markets closed

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.2900-0.0600 (-2.55%)
At close: 04:00PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • B
    Bobby
    Explain to me how $PRTK is not at least up 20% today on the news that $GSK is now a 25% shareholder in $SPRO and has given them $60mil to continue their pursuit of the phase 3 study in an oral only UTI drug. $PRTK has 2 approved drugs, 1 of which Nuzyra has 2 approved indications for oral only, and fast tracking on a 3rd orphan status disease with high cost of treatment (aka big dollars coming $PRTK way). Not to mention the potential for anthrax treatment and battlefield wound treatment in the coming global conflicts we are dead staring in the face.

    This stock is so manipulated due to the low volume, the big fish are keeping it suppressed until a 200%+ day comes, then a buyout shortly after. Stay long, stay strong
  • d
    dom
    This one will go way up. Fly. In due time.
  • C
    Carmine
    Prtk should be bought out by a big pharma company,they get a top line antibiotic,a 300 million Barda contract,and a 165 million rite off,the longer they wait the more expensive it will become because of the increased earnings,let’s see who wants to be the company with the best antibiotic on the market?
  • I
    IFTNorh
    Jeffies price targets 13+ analyst median price target $20/ share
  • B
    Bobby
    Company hired 14 new employees from latest inducement grant filings. This compared to 2-3 typically announced on these.

    Sounds like sales are ramping up in an accelerated manner, due mainly to hospital surgeries delayed from covid being undertaken, as well as uptick in Antibiotic resistant infections due to overuse of genetic treatment from covid Era.

    Not only do we hold an undervalued company, but one that is now experiencing accelerated sales growth. This earnings should wake the market up.
  • I
    IFTNorh
    Weekly scrips avg 2m now bodes well.. estimated Revenue
    Report after the close today 28-32 milion
  • J
    Jens
    where is cramers BUY BUY BUY button?
  • K
    KK
    Share price will not move higher until they stop issuing shares every single month. It is diluting the shareholders value.
  • O
    Ooi
    What makes prtk attractive as compared to gamida and bluebio?
  • C
    Carmine
    Should have been up over 10% on those numbers .
  • O
    Ooi
    Prtk had broken its support..hope it hold at 2.5 psychological level.. GLTA
  • C
    Carmine
    When did the debt go to 258 million,thought it was 165?
  • C
    Carmine
    Getting ready to take off.
  • j
    jos p
    They beat projected sales,
  • C
    Carmine
    Over 30 million this quarter.
  • M
    Market Analyst
    https://tradeideas.tips/Trade-Ideas-Save-499
  • C
    Carmine
    Expect big numbers coming in the next earnings report,breaking records every week in sales.
  • O
    Ooi
    Come to atra for good uptrend momentum..now great time to buy..hv a peek..no harm..
  • O
    Ooi
    Like i said bfr..prtk needs to break 3 and stay above 2.8...seems less momentum ytrdy trade....come to another biotech cmpny..ATRA...financially sound..and cheap undervalue and will be green closing today and tmrw..after already 3 red days...i forsee..
  • O
    Ooi
    Anyone can gv me a quick info..of how come prtk has such a high tp of 18.50 from yahoo finance although ER didnt hit its target? And wht is the catalyst contribute to ytrdy trade up 12%?